<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Ten consecutive patients were entered on a pilot study--for the treatment of children with far-advanced Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo>--which was conducted at the Roswell Park Memorial Institute (R.P.M.I.) and the University of Rochester Medical Center (U. of R.) </plain></SENT>
<SENT sid="1" pm="."><plain>With the use of high-dose <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (HDC), intermediate-dose <z:chebi fb="0" ids="44185">methotrexate</z:chebi> (IDM), <z:chebi fb="0" ids="28445">vincristine</z:chebi> (VCR), <z:chebi fb="0" ids="8382">prednisone</z:chebi> (PRED), and intrathecal (IT) chemotherapy, nine of these 10 children achieved a complete remission (CR), and six of these nine children have remained in CR for more than 3 years and are likely cured of their disease </plain></SENT>
<SENT sid="2" pm="."><plain>This regimen had significant, but generally manageable, toxicity </plain></SENT>
<SENT sid="3" pm="."><plain>A single patient with <z:hpo ids='HP_0001251'>ataxia</z:hpo>-<z:hpo ids='HP_0001009'>telangiectasia</z:hpo> died during induction therapy of <z:hpo ids='HP_0002090'>pneumonia</z:hpo> and a <z:hpo ids='HP_0002239'>gastrointestinal hemorrhage</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>A single patient with severe <z:e sem="disease" ids="C0085692" disease_type="Disease or Syndrome" abbrv="">hemorrhagic cystitis</z:e> required the substitution of <z:chebi fb="1" ids="16040">cytosine</z:chebi> <z:chebi fb="0" ids="22601">arabinoside</z:chebi> for <z:chebi fb="0" ids="4027">cyclophosphamide</z:chebi> (Cytoxan) in the regimen </plain></SENT>
<SENT sid="5" pm="."><plain>One of five children presenting with bone marrow involvement survives </plain></SENT>
<SENT sid="6" pm="."><plain>Such involvement appears to place patients at greater risk for developing meningeal disease </plain></SENT>
<SENT sid="7" pm="."><plain>Attempts at more aggressive methods of central <z:mp ids='MP_0008912'>nervous</z:mp> system (<z:chebi fb="7" ids="29425,29426,29441,29447">CNS</z:chebi>) prophylaxis should be employed in this group of patients </plain></SENT>
</text></document>